Actress’ impact on genetic testing for breast, ovarian cancer is ‘global and long lasting’
Sept. 18, 2014
| By Mary Engel / Fred Hutch News Service
The so-called Angelina Jolie effect not only is real but has been “global and long lasting,” leading to a twofold increase in the number of women getting genetic testing to help determine their risk for hereditary breast cancer, according to new studies from the United Kingdom and Canada.
PHS findings on BRCA mutations underscore importance of genetic testing in younger patients
April 12, 2010
| By Kristen Woodward
Fred Hutchinson Cancer Research Center Public Health Sciences Division’s Dr. Kathi Malone and colleagues found that women with breast cancer before age 55 who carry an inherited mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 are four times more likely to develop cancer in the breast opposite, or contralateral, to their initial tumor as compared to breast cancer patients without these genetic defects.